Abstract
<b>Introduction:</b> There is an urgent need for highly sensitive diagnostics to match advances in pulmonary therapeutics, particularly in cystic fibrosis (CF). Non-contrast Ultrashort Echo Time (UTE) and phase-resolved functional lung (PREFUL) MRI provide high resolution structural and regionally-localized functional data, respectively. <b>Aim:</b> To use UTE and PREFUL MRI to assess lung structure and function in people with CF (pwCF). <b>Methods:</b> 7 pwCF (12-32 years; n=4 homozygous for p.Phe508del mutation) were imaged on a Philips 3T Ingenia MRI scanner. PREFUL was analysed using k-means segmentation to generate ventilation maps and quantify regional lung function as ventilation defect percentage (VDP). <b>Results:</b> Bronchiectatic and cystic changes were demonstrated with UTE. PREFUL VDP ranged from 8.09-42.23% (median: 19.4%). Ventilation defects were seen in all pwCF, including those with FEV<sub>1</sub> > 100% (n=3).(Fig 1) <b>Conclusion:</b> This study demonstrates comprehensive lung MRI assessment in CF. UTE provides structural imaging without ionizing radiation. PREFUL MRI provides sensitive and regionally localized functional data, similar to <sup>129</sup>Xe MRI, but is easier to perform. Together, these techniques could be used to assess response to therapeutics and potentially disease progression in pwCF in the future.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.